Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2000
06/14/2000CN1053365C Nutrient for youngsters
06/14/2000CN1053349C Peristrophe japonica liniment and its prepn.
06/14/2000CN1053341C Use of nadh and nadph or their salts in pharmaceutic
06/14/2000CN1053340C Medicine with function of regulating gastrointestinal tract capable of resisting fatigue
06/14/2000CN1053339C Controlled release morphine prepn.
06/14/2000CN1053338C Cantharidate antiviral pharmaceutical and its prep.
06/14/2000CN1053337C Medicine for treating disease of autoimmunization system
06/13/2000US6075151 Inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related hyperlipidemia, cardiovascular disorders
06/13/2000US6075135 3,4-di-O,N-Protected-4-amino-2,4,6-trideoxy-2-fluoro-L-manno-pyranosyl halide and a process for its preparation
06/13/2000US6075133 Increased acid stability and enhanced bactericidal activity
06/13/2000US6075058 Consisting essentially of a carotenoid, cholesterol, a triglyceride, and a phospholipid, wherein at least 15% of said composition by weight is a phospholipid
06/13/2000US6075056 Antifungal/steroid topical compositions
06/13/2000US6075054 Antiarrhythmic pharmaceuticals having a cardioprotective component for infarct prophylaxis and infarct treatment as well as for the treatment of angina pectoris
06/13/2000US6075053 Administering to a patient in need of treatment an effective amount of a thiol or reducible disulfide compound
06/13/2000US6075052 Skin external preparation
06/13/2000US6075050 Condensation polymers of an aldehyde and aromatic sulfonic acids and fractions thereof, such as formaldehyde naphthalenesulfonic acid condensation polymers
06/13/2000US6075048 Administering to the child a higher dose, as measured on a mg/kg basis, of bambuterol, or of a pharmaceutically acceptable salt thereof, than the adult dose of bambuterol; for treatment of asthma
06/13/2000US6075046 For the therapeutic or prophylactic treatment of humans suffering from or prone to degenerative diseases and conditions of the vascular and nervous system which are associated with oxidative stress
06/13/2000US6075045 Method of treating paralysis of the extremities caused by cerebral infarction
06/13/2000US6075044 Heterocyclic derivatives as inhibitors of purine salvage phosphoribosyltransferases
06/13/2000US6075043 Parasiticidal pyrazoles
06/13/2000US6075041 Cyclic amides
06/13/2000US6075040 Obesity and diabetes
06/13/2000US6075039 5HT receptor binding benzimidazolylpiperidines
06/13/2000US6075038 Alpha 1a adrenergic receptor antagonists
06/13/2000US6075037 Endothelin receptor antagonists
06/13/2000US6075034 Spiro[piperidine-4,1'-pyrrolo [3,4-C] pyrrole]derivatives
06/13/2000US6075033 Anthranilic acid diamides derivatives, their preparation and pharmaceutical use as anti-gastrin agents
06/13/2000US6075032 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
06/13/2000US6075031 Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders
06/13/2000US6075028 Method of treating Tourette's syndrome and related CNS disorders
06/13/2000US6075027 Treatment and prevention of hepatic disorders
06/13/2000US6075026 Certain substituted 1-aryl-3-piperazin-1'-yl propanones
06/13/2000US6075025 Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
06/13/2000US6075024 Methods for treating infection using optically pure (S)-lomefloxacin
06/13/2000US6075021 1H-pyrido[3,4-b]indole-4-carboxamide derivatives, preparation and application thereof in therapeutics
06/13/2000US6075020 Method of regulating immune function
06/13/2000US6075018 Tranquilizers
06/13/2000US6075017 Compositions for the treatment of dandruff
06/13/2000US6075014 Inhibitors of β-lactamases and uses therefor
06/13/2000US6075013 Cardiovascular disorders
06/13/2000US6075011 6-O-substituted erythromycin compounds and method for making same
06/13/2000US6075001 Activation of peroxy bleach
06/13/2000US6074841 Don-1 gene and polypeptides and uses therefor
06/13/2000US6074839 Transforming growth factor αHI
06/13/2000US6074670 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it
06/13/2000US6074666 Liposome compositions of porphyrin photosensitizers
06/13/2000US6074661 Sterile bioerodible occular implant device with a retinoid for improved biocompatability
06/13/2000US6074659 Therapeutic inhibitor of vascular smooth muscle cells
06/13/2000US6074658 Treatment of sickle cell anemia crises with fructose-1, 6-diphosphate as an analgesic drug
06/13/2000US6074657 Administration of an injectable antibiotic in the ear of an animal
06/13/2000US6074653 Topical applicable
06/13/2000US6074649 Recombinant composition containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
06/13/2000US6074644 Cytotoxic activity
06/13/2000US6074637 Modifying cells by transfection with dna
06/13/2000US6074625 Using complex of boron isotope
06/13/2000US6074390 Spine distraction implant and method
06/13/2000CA2206164C Viscous liquid conditioning topical germicides
06/13/2000CA2157196C Inhibitors of herpes viral ribonucleotide reductase
06/13/2000CA2146127C Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
06/13/2000CA2125667C Fluorocarbon aerosol medicaments
06/13/2000CA2107014C Therapeutic agent for parkinson's disease
06/13/2000CA2085878C Bis-benzo or benzopyrido cyclo hepta piperidene, piperidylidene and piperazine compounds and compositions
06/13/2000CA2048450C Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
06/13/2000CA2030732C Thiophene derivatives; process for preparing the same and pharmaceutical compositions containing them
06/13/2000CA2014062C Pyridine derivatives
06/13/2000CA2010982C Osteogenesis promotion with use of vitamin d derivatives
06/13/2000CA2002182C Compositions for treating the premenstrual or late luteal phase syndrome and methods for their use
06/13/2000CA2000979C Specific ligands of receptors of oestrogen and progesterone steroidal hormones, use and synthetic intermediates
06/13/2000CA1341027C Phosphonoalkylpurine derivatives
06/13/2000CA1341025C Substituted silyl alkylene amines
06/13/2000CA1341024C Benzo-fused cycloalkane and oxa- and thia-, cycloalkane trans-1, 2-diamine derivatives
06/13/2000CA1341023C Peptide derivatives
06/09/2000WO2000020019A3 A composition for the prevention and/or treatment of atherosclerosis
06/09/2000CA2289951A1 Processes for preparation of marek's disease virus using continuous avian cell lines
06/08/2000WO2000033161A2 Methods to reduce variance in treatment studies using genotyping
06/08/2000WO2000033069A1 Substance containing shiitake mushroom hypha extract for screening lak activity and method for screening lak activity by using the same
06/08/2000WO2000032818A1 Antisense modulation of cellular inhibitor of apoptosis-2 expression
06/08/2000WO2000032816A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression
06/08/2000WO2000032803A2 Novel nucleic acid transferring agents, compositions containing them and uses
06/08/2000WO2000032794A2 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032784A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032773A1 Compositions and methods for increasing bone mineralization
06/08/2000WO2000032769A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
06/08/2000WO2000032764A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000WO2000032656A2 Polymers containing spirobicyclic ammonium moieties and use thereof
06/08/2000WO2000032638A1 Polysaccharide chiral esters, one of the methods for preparing them and their uses for obtaining optically enriched acids or chiral chromatography
06/08/2000WO2000032624A2 Uncoupling protein 5 - ucp5
06/08/2000WO2000032616A1 Hygromycin a derivatives as antibacterial agents
06/08/2000WO2000032607A1 Crystalline salts of a carbapenem antibiotic
06/08/2000WO2000032606A1 IMIDAZO[4,5-b]PYRIDINIUMMETHYL-CONTAINING CEPHEM COMPOUNDS HAVING BROAD ANTIBACTERIAL SPECTRUM
06/08/2000WO2000032600A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/08/2000WO2000032599A1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
06/08/2000WO2000032598A1 Methods and compositions for treating inflammatory diseases utilizing inhibitors of tumor necrosis factor activity
06/08/2000WO2000032597A1 Process for the production of paroxetine hydrochloride propan-2-ol solvate
06/08/2000WO2000032595A1 Process for the production of paroxetine hydrochloride acetone solvate
06/08/2000WO2000032594A1 Mixed paroxetine propan-2-ol solvates
06/08/2000WO2000032593A1 Method of producing paroxetine hydrochloride
06/08/2000WO2000032592A1 Process for the preparation of paroxetine hydrochloride
06/08/2000WO2000032590A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
1 ... 6302 6303 6304 6305 6306 6307 6308 6309 6310 6311 6312 6313 6314 6315 6316 6317 6318 6319 6320 6321 6322 ... 7860